Highguard's central mode is genuinely cool, but it's overstuffed with FPS trends that should go away for a while.
Amgen has reported encouraging mid-stage results for its olpasiran candidate for reducing lipoprotein(a) – a risk factor for atherosclerotic cardiovascular disease – and now plans to move ahead ...
MSD and Moderna have kicked off another phase 3 trial of their personalised cancer vaccine V940 used alongside MSD's PD-1 inhibitor Keytruda, this time focusing on patients with earlier-stage ...
Google DeepMind’s Genie 3 builds interactive 3D spaces from images and text, with first- or third-person views, so you can ...
Genie 3 is a “general-purpose world model capable of generating diverse, interactive environments.” Google Project ...
Forde's breadth of experience across creative technology and global platforms positions him to help scale Maxon's ...
Disney names Josh D’Amaro as its next CEO, replacing Bob Iger and ending one of Hollywood’s most closely watched leadership ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results